Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

China · Delayed Price · Currency is CNY

11.05

-0.24 (-2.13%)

Mar 20, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Manufacturing	2.14B	1.63B	1.20B	938.97M	-
Pharmaceutical Manufacturing Growth	31.16%	36.10%	27.94%	-	-
Total	2.14B	1.63B	1.20B	938.97M	-
Total Growth	31.16%	36.10%	27.94%	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	2.14B	1.63B	1.20B	938.97M	630.22M
China Growth	31.16%	36.10%	27.94%	48.99%	-28.69%
Total	2.14B	1.63B	1.20B	938.97M	630.22M
Total Growth	31.16%	36.10%	27.94%	48.99%	-28.69%

Source: S&P Global Market Intelligence.